Publikationen, an denen er mitarbeitet Francisco Orallo Cambeiro (26)

2012

  1. Monoamino oxidase A: An interesting pharmacological target for the development of multi-target QSAR

    Mini-Reviews in Medicinal Chemistry, Vol. 12, Núm. 10, pp. 947-958

2011

  1. Chromone, a privileged scaffold for the development of monoamine oxidase inhibitors

    Journal of Medicinal Chemistry, Vol. 54, Núm. 14, pp. 5165-5173

2010

  1. Chromone-2- and -3-carboxylic acids inhibit differently monoamine oxidases A and B

    Bioorganic and Medicinal Chemistry Letters, Vol. 20, Núm. 9, pp. 2709-2712

  2. Synthesis and vasorelaxant and platelet antiaggregatory activities of a new series of 6-Halo-3-phenylcoumarins

    Molecules, Vol. 15, Núm. 1, pp. 270-279

2009

  1. A new series of 3-phenylcoumarins as potent and selective MAO-B inhibitors

    Bioorganic and Medicinal Chemistry Letters, Vol. 19, Núm. 12, pp. 3268-3270

  2. Alignment-free prediction of a drug-target complex network based on parameters of drug connectivity and protein sequence of receptors

    Molecular Pharmaceutics, Vol. 6, Núm. 3, pp. 825-835

  3. Synthesis and evaluation of 6-methyl-3-phenylcoumarins as potent and selective MAO-B inhibitors

    Bioorganic and Medicinal Chemistry Letters, Vol. 19, Núm. 17, pp. 5053-5055

2008

  1. Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors

    Journal of Medicinal Chemistry, Vol. 51, Núm. 21, pp. 6740-6751

2007

  1. Quantitative structure vasodilatory activity relationship - Synthesis and "in silico" and "in vitro" evaluation of resveratrol-coumarin hybrids

    QSAR and Combinatorial Science, Vol. 26, Núm. 3, pp. 317-332

2006

  1. Design, synthesis, and vasorelaxant and platelet antiaggregatory activities of coumarin-resveratrol hybrids

    Bioorganic and Medicinal Chemistry Letters, Vol. 16, Núm. 2, pp. 257-261

2004

  1. Effects of cis-resveratrol on inflammatory murine macrophages: Antioxidant activity and down-regulation of inflammatory genes

    Journal of Leukocyte Biology, Vol. 75, Núm. 6, pp. 1156-1165

2003

  1. In vivo and in vitro pharmacological studies of a new hypotensive compound (QF0301B) in rat: Comparison with prazosin, a known α1- adrenoceptor antagonist

    Vascular Pharmacology, Vol. 40, Núm. 2, pp. 97-108

2002

  1. Synthesis and vasorelaxant activity of new coumarin and furocoumarin derivatives

    Bioorganic and Medicinal Chemistry Letters, Vol. 12, Núm. 5, pp. 783-786

2000

  1. Study of the in vivo and in vitro cardiovascular effects of four new analogues of ketanserin: Implication of 5-HT(2A) and α1 adrenergic antagonism in their hypotensive effect

    Biological and Pharmaceutical Bulletin, Vol. 23, Núm. 5, pp. 558-565

1998

  1. Preliminary study of the potential vasodilator effects on rat aorta of centaurein and centaureidin, two flavonoids from Centaurea corcubionensis

    Planta Medica, Vol. 64, Núm. 2, pp. 116-119

1993

  1. Cyproheptadine analogues: Synthesis, antiserotoninergic activity, and structure‐activity relationships

    Journal of Pharmaceutical Sciences, Vol. 82, Núm. 11, pp. 1090-1093

1992

  1. Synthesis, hypotensive and diuretic activities of several 3-hydrazino-5,6-dihydrobenzo[h]cinnolines. Part 10: Pyridazine derivatives

    Pharmazie, Vol. 47, Núm. 8, pp. 574-577

1991

  1. Pyridazine Derivatives, VIII1): Synthesis and Antihypertensive Activity of 6‐(2‐Thienyl)‐5‐aminomethyl‐3‐hydrazino‐pyridazines

    Archiv der Pharmazie, Vol. 324, Núm. 7, pp. 455-460

  2. Synthesis and Antidopaminergic Activity of Some 3-(Aminomethyl)tetralones as Analogues of Butyrophenone

    Journal of Medicinal Chemistry, Vol. 34, Núm. 7, pp. 2242-2247

1989

  1. Pyridazine Derivatives, VII. Synthesis and Hypotensive Activity of 3‐Hydrazinocycloalkyl[1,2‐c]pyridazines and their Derivatives

    Archiv der Pharmazie, Vol. 322, Núm. 6, pp. 331-336